Pfizer to apply for vaccine use in 3rd week of Nov. at earliest

U.S. pharmaceutical giant Pfizer Inc. said Friday that its application for emergency use authorization in the United States for its potential coronavirus vaccine will take place no earlier than the third week of November.The announcement may be a disappointment to President Donald Trump, who has been raising expectations that vaccines could be ready around the time of the Nov. 3 presidential election in an apparent bid to boost his faltering electoral prospects.Pfizer is one among several companies in the midst of final-stage clinical trials for potential coronavirus vaccines in the country…READ FULL ARTICLE